---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-23-019630"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T16:45:10.414078+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salona Global appoints Natalia Vakhitova as CFO after Dennis Nelson resigns

## Summary
- Dennis Nelson resigned as CFO, CAO and Treasurer effective Oct 17, 2023; no dispute with company.
- Natalia Vakhitova appointed CFO effective Oct 18, 2023; annual base salary of $250,000.
- Vakhitova had been Corporate Senior Controller of subsidiary Biodex Medical Systems since Aug 2023.
- She previously served as Interim CFO of subsidiary Inspira Financial Company (2017-2018).

## SEC filing metadata
- accession: 0001062993-23-019630
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299323019630/0001062993-23-019630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299323019630/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-23-019630
- JSON: https://secwatch.observer/filing/0001062993-23-019630.json
- Plain text: https://secwatch.observer/filing/0001062993-23-019630.txt

## Key facts
- Executive change
  Dennis Nelson resigned as Chief Financial Officer, Chief Accounting Officer and Treasurer at EVOME MEDICAL TECHNOLOGIES INC..
  - Action: resigned
  - Role: Chief Financial Officer, Chief Accounting Officer and Treasurer
  source text: On October 17, 2023, Dennis Nelson, the Company's Chief Financial Officer, Chief Accounting Officer and Treasurer, informed the Company of his resignation effective on October 17, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323019630/0001062993-23-019630-index.htm
- Executive change
  Natalia Vakhitova was appointed as Chief Financial Officer at EVOME MEDICAL TECHNOLOGIES INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On October 18, 2023, the Company appointed Natalia Vakhitova to serve as the Company's Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299323019630/0001062993-23-019630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
